Rainier Therap 
Welcome,         Profile    Billing    Logout  
 1 Product   0 Diseases  1 Product   0 Trials   84 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
vofatamab (B-701) / Rainier Therap
NCT05363605: A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Terminated
1/2
6
US, RoW
[225Ac]-FPI-1966, [111In]-FPI-1967, vofatamab
Fusion Pharmaceuticals Inc.
Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma, Susceptible FGFR3 Genetic Alterations, FGFR3, FGFR3 Overexpression, FGFR3 Receptor, FGFR3 Protein Overexpression, Ovarian Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Lung Cancer, Gastric Cancer
09/23
09/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
vofatamab (B-701) / Rainier Therap
NCT05363605: A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Terminated
1/2
6
US, RoW
[225Ac]-FPI-1966, [111In]-FPI-1967, vofatamab
Fusion Pharmaceuticals Inc.
Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma, Susceptible FGFR3 Genetic Alterations, FGFR3, FGFR3 Overexpression, FGFR3 Receptor, FGFR3 Protein Overexpression, Ovarian Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Lung Cancer, Gastric Cancer
09/23
09/23

Download Options